UnitedHealth Group Incorporated (NYSE:UNH) Holdings Increased by Atticus Wealth Management LLC

Atticus Wealth Management LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 53.8% during the second quarter, Holdings Channel reports. The institutional investor owned 612 shares of the healthcare conglomerate’s stock after acquiring an additional 214 shares during the period. Atticus Wealth Management LLC’s holdings in UnitedHealth Group were worth $314,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. increased its position in shares of UnitedHealth Group by 1.4% in the first quarter. Vanguard Group Inc. now owns 80,630,913 shares of the healthcare conglomerate’s stock worth $41,119,347,000 after acquiring an additional 1,147,051 shares in the last quarter. State Street Corp increased its position in shares of UnitedHealth Group by 1.6% in the first quarter. State Street Corp now owns 46,274,771 shares of the healthcare conglomerate’s stock worth $23,598,745,000 after acquiring an additional 714,903 shares in the last quarter. Capital World Investors increased its position in shares of UnitedHealth Group by 2.8% in the first quarter. Capital World Investors now owns 34,805,861 shares of the healthcare conglomerate’s stock worth $17,750,351,000 after acquiring an additional 935,552 shares in the last quarter. Capital International Investors increased its position in shares of UnitedHealth Group by 4.3% in the fourth quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock worth $9,713,058,000 after acquiring an additional 790,219 shares in the last quarter. Finally, Capital Research Global Investors grew its position in UnitedHealth Group by 8.3% during the first quarter. Capital Research Global Investors now owns 19,273,691 shares of the healthcare conglomerate’s stock valued at $9,829,129,000 after purchasing an additional 1,482,338 shares in the last quarter. Institutional investors and hedge funds own 87.25% of the company’s stock.

Insider Buying and Selling

In related news, CEO Andrew Witty sold 11,376 shares of the stock in a transaction dated Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the sale, the chief executive officer now owns 76,559 shares in the company, valued at approximately $40,415,496.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CAO Thomas E. Roos sold 465 shares of the firm’s stock in a transaction dated Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the transaction, the chief accounting officer now owns 34,786 shares of the company’s stock, valued at approximately $18,866,882.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Andrew Witty sold 11,376 shares of the firm’s stock in a transaction dated Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the transaction, the chief executive officer now directly owns 76,559 shares in the company, valued at approximately $40,415,496.10. The disclosure for this sale can be found here. Insiders sold 139,051 shares of company stock worth $74,450,958 in the last quarter. 0.40% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts recently commented on UNH shares. UBS Group boosted their price objective on shares of UnitedHealth Group from $545.00 to $570.00 and gave the company a “neutral” rating in a research report on Thursday, July 21st. Sanford C. Bernstein downgraded shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price objective on the stock. in a research report on Thursday, May 26th. They noted that the move was a valuation call. Loop Capital initiated coverage on shares of UnitedHealth Group in a research report on Thursday, June 16th. They set a “buy” rating and a $575.00 price objective on the stock. Credit Suisse Group lifted their target price on shares of UnitedHealth Group from $575.00 to $579.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Finally, SVB Leerink lifted their target price on shares of UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Three investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $586.40.

UnitedHealth Group Trading Up 1.1 %

Shares of UnitedHealth Group stock opened at $517.46 on Friday. The firm has a market capitalization of $484.02 billion, a PE ratio of 27.02, a price-to-earnings-growth ratio of 1.61 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. The company’s fifty day moving average price is $530.11 and its two-hundred day moving average price is $512.45. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.24 by $0.33. The firm had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business’s revenue for the quarter was up 12.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $4.70 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Monday, September 12th were given a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.28%. The ex-dividend date was Friday, September 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.46%.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.